Substance Abuse Pre-Treatment Screening Study

This study is currently recruiting patients.
Verified by National Institute on Drug Abuse (NIDA) February 2007

Sponsored by: National Institute on Drug Abuse (NIDA) Information provided by: National Institute on Drug Abuse (NIDA) ClinicalTrials.gov Identifier: NCT00439049

Purpose

The overarching goal of this project is to have a consolidated consent and evaluation procedure that will lead potential subjects to the most appropriate clinical trial or human laboratory study (and its consent process) for their presenting concerns or interests. A second purpose is to have a consolidated intake data base on which secondary analyses can be conducted.

Condition
Cocaine Abuse Cocaine Dependence Opiate Dependence Alcohol Dependence Substance Abuse

MedlinePlus related topics: Alcoholism; Cocaine; Drug Abuse

Study Type: Observational
Study Design: Screening, Cross-Sectional, Defined Population, Prospective Study

Official Title: General Evaluation of Eligibility for Substance Abuse/Dependence Research

Further study details as provided by National Institute on Drug Abuse (NIDA):

Expected Total Enrollment: 7500

Study start: October 2005

Approximately 1500 candidates per year will respond to advertisements and will complete preliminary telephone screening without identifiers. Appropriate candidates will be given appointment times and on arrival will undergo the consent process for evaluation. A complete medical, social, psychiatric, and drug use history will be obtained. Subjects fulfilling general health inclusion requirements will then be offered an appropriate study for which the specific consent will be obtained. The evaluation period will be no more than one day with all results evaluated within the two following days. Acceptable candidates will then be invited to complete the study specific consent.

Eligibility

Ages Eligible for Study: 18 Years - 60 Years, Genders Eligible for Study: Both

Accepts Healthy Volunteers

Criteria

Inclusion Criteria:

• Willing and able to participate in 3- to 6-month treatment program.
• At least 18 years of age.
• Seeking treatment for substances of abuse including (cocaine, opiates, and alcohol).
• Generally physically healthy.

Exclusion Criteria:

• Pregnant or breastfeeding.
• Mandated by the courts/parole officers to attend treatment.
• Not seeking treatment for substances of abuse.
• Plans to move from the Houston area within the 3- to 6-month treatment period.
• Seeking treatment for a substance for which the TRC has no current trial.

Location and Contact Information

Please refer to this study by ClinicalTrials.gov identifier NCT00439049

Shelly L Sayre, MPH 713-500-2820 Shelly.L.Sayre@uth.tmc.edu
Ann D. Garcia, MA, RN 713-500-2804 Ann.D.Garcia@uth.tmc.edu

United States, Texas
University of Texas Medical School- Houston, Dept. of Psychiatry Mental Sciences Institute, Houston, Texas, 77030, United States; Recruiting

Shelly L Sayre, MPH 713-500-2820 Shelly.L.Sayre@uth.tmc.edu
Mary A Dhir 713-500-2874 Mary.A.Dhir@uth.tmc.edu
John Grabowski, PhD, Principal Investigator

Study chairs or principal investigators

John Grabowski, PhD, Principal Investigator, University of Texas-Houston
Joy M. Schmitz, PhD, Principal Investigator, University of Texas-Houston
Frederick G Moeller, MD, Principal Investigator, University of Texas-Houston
Angela L Stotts, PhD, Principal Investigator, University of Texas-Houston

More Information

Study ID Numbers: NIDA-09262-13; P50-09262-13
Last Updated: February 21, 2007
Record first received: February 21, 2007
ClinicalTrials.gov Identifier: NCT00439049
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2007-02-22